(Q84271322)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21640121%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

Improvement of left ventricular diastolic function induced by β-blockade: a comparison between nebivolol and metoprolol (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21640121%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21640121%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Yuehua Fang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21640121%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Lionel Nicol

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21640121%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Najah Harouki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21640121%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Christelle Monteil

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21640121%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Didier Wecker

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21640121%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Manuelle Debunne

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21640121%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Fabrice Bauer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21640121%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Françoise Lallemand

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21640121%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Christian Thuillez

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21640121%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Paul Mulder

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21640121%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

24 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21640121%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular and Cellular Cardiology

3 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21640121%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21640121%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21640121%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

168-176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21640121%20AND%20SRC:MED&resulttype=core&format=json

The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study

3 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Cardiovascular morbidity and mortality associated with the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Nebivolol induces NO-mediated relaxations of rat small mesenteric but not of large elastic arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Involvement of the beta3 adrenoceptor in nebivolol-induced vasorelaxation in the rat aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Antioxidant activity of nebivolol in the rat aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

The failing diabetic heart: focus on diastolic left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Diastolic Stiffness of the Failing Diabetic Heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Diastolic heart failure: a misNOmer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

NO produced by endothelial NO synthase is a mediator of delayed preconditioning-induced endothelial protection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Selenium diet-supplementation improves cocaine-induced myocardial oxidative stress and prevents cardiac dysfunction in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Mixed beta3-adrenoceptor agonist and alpha1-adrenoceptor antagonist properties of nebivolol in rat thoracic aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Myocardial perfusion imaging using a non-contrast agent MR imaging technique.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Myocardial blood flow mapping in mice using high-resolution spin labeling magnetic resonance imaging: influence of ketamine/xylazine and isoflurane anesthesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Impaired NO-dependent dilation of skeletal muscle arterioles in hypertensive diabetic obese Zucker rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Angiotensin-converting enzyme inhibition reduces lipid deposits in myocardium and improves left ventricular function of obese zucker rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Cardiovascular protective role of a low-dose antihypertensive combination in obese Zucker rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Elimination of exercise-induced regional myocardial dysfunction by a bradycardiac agent in dogs with chronic coronary stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Role of heart rate reduction in the treatment of exercise-induced myocardial ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Mechanism of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Nebivolol Prevents Vascular NOS III Uncoupling in Experimental Hyperlipidemia and Inhibits NADPH Oxidase Activity in Inflammatory Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Cardiovascular protective effects of nebivolol in Zucker diabetic fatty rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Loss of arterial and renal nitric oxide bioavailability in hypertensive rats with diabetes: effect of beta-blockers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Mechanisms of coronary dysfunction in obesity and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Impaired coronary flow reserve in patients with metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Altered vasodilator role of nitric oxide synthase in the pancreas, heart and brain of rats with spontaneous type 2 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Reduced plasma volume and mesenteric vascular reactivity in obese Zucker rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Role of gp91phox-containing NADPH oxidase in left ventricular remodeling induced by intermittent hypoxic stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Hypoxic reperfusion of the ischemic heart and oxygen radical generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Effect of NO donors on LV diastolic function in patients with severe pressure-overload hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Oxidative Stress-Dependent Impairment of Cardiac-Specific Transcription Factors in Experimental Diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Altered expression of the adenine nucleotide translocase isoforms and decreased ATP synthase activity in skeletal muscle mitochondria in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Zucker obese rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.05.012

10.1016/J.YJMCC.2011.05.012

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21640121%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference